{
    "medicine_id": "f65042dde09d5ca1718348105933af256d725824",
    "platform_id": "DB00072",
    "metadata": {
        "name": "Herceptin 150 mg Injection powder for solution",
        "composition": "150 mg Trastuzumab",
        "clinical_particulars": {
            "therapeutic_indications": "For the adjuvant treatment of HER2 overexpressing breast cancer trastuzumab is indicated in several clinical settings as part of a treatment regimen consisting of doxorubicin cyclophosphamide and either paclitaxel or docetaxel as part of a treatment regimen with docetaxel and carboplatin or as monotherapy following multi modality anthracycline based therapy L14015 Trastuzumab is indicated as a first line treatment in combination with paclitaxel for metastatic HER2 overexpressing breast cancer and as monotherapy in patients who have previously received one or more chemotherapy regimens in the metastatic setting L14015 Trastuzumab is also indicated in combination with cisplatin and capecitabine or 5 fluorouracil for the treatment of patients with HER2 overexpressing metastatic gastric or gastroesophageal junction adenocarcinoma who have not received prior treatment for metastatic disease L14015 Trastuzumab is indicated for subcutaneous administration in combination with either hyaluronidase L14132 or both hyaluronidase and pertuzumab L14510 for the treatment of adults with HER 2 positive breast cancers",
            "contraindications": {
                "disease": "There is no experience with overdosage of trastuzumab in clinical trials single doses 8 mg kg have not been tested in humans L14015 Trastuzumab can contribute to the development of ventricular dysfunction and congestive heart failure particularly when used in combination or temporally adjacent to other cardiotoxic chemotherapies such as anthracyclines L14015",
                "pregnancy": "NA",
                "machine_ops": "NA",
                "pharmacodynamics": "Trastuzumab exerts an antitumour activity and is used in the treatment of HER2 positive breast cancer HER2 protein overexpression is observed in 20 30 of primary breast cancers A40277 thus HER2 presents as a useful therapeutic target for the treatment of breast cancers Trastuzumab has been shown in both _in vitro_ assays and in animals to inhibit the proliferation of human tumour cells that overexpress HER2 It works as a mediator of antibody dependent cellular cytotoxicity where it binds as an antibody to cells over expressing HER2 leading to preferential cell death Trastuzumab was also shown to inhibit angiogenesis of tumor cells _in vivo_ A121 Higher doses and longer dosing intervals show no significant benefit over standard dose schedules A40276 In patients with HER2 positive solid tumours trastuzumab did not exert any clinically significant QTc interval duration L14015",
                "excipients": "NA",
                "incompatibilities": [
                    {
                        "drugbank-id": "DB06643",
                        "description": "The risk or severity of adverse effects can be increased when Denosumab is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00108",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Natalizumab"
                    },
                    {
                        "drugbank-id": "DB00337",
                        "description": "The risk or severity of adverse effects can be increased when Pimecrolimus is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB01656",
                        "description": "Roflumilast may increase the immunosuppressive activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB06688",
                        "description": "The therapeutic efficacy of Sipuleucel T can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00012",
                        "description": "The risk or severity of Thrombosis can be increased when Darbepoetin alfa is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00016",
                        "description": "The risk or severity of Thrombosis can be increased when Erythropoietin is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB08894",
                        "description": "The risk or severity of Thrombosis can be increased when Peginesatide is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB09107",
                        "description": "The risk or severity of Thrombosis can be increased when Methoxy polyethylene glycol epoetin beta is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB01015",
                        "description": "The risk or severity of myelosuppression can be increased when Sulfamethoxazole is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB01229",
                        "description": "The serum concentration of Paclitaxel can be decreased when it is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00255",
                        "description": "Diethylstilbestrol may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00269",
                        "description": "Chlorotrianisene may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00286",
                        "description": "Conjugated estrogens may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00655",
                        "description": "Estrone may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00783",
                        "description": "Estradiol may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00890",
                        "description": "Dienestrol may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00977",
                        "description": "Ethinylestradiol may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB01357",
                        "description": "Mestranol may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB04573",
                        "description": "Estriol may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB04574",
                        "description": "Estrone sulfate may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB04575",
                        "description": "Quinestrol may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB07931",
                        "description": "Hexestrol may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB09070",
                        "description": "Tibolone may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB09317",
                        "description": "Synthetic Conjugated Estrogens A may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB09318",
                        "description": "Synthetic Conjugated Estrogens B may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB09369",
                        "description": "Polyestradiol phosphate may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB09381",
                        "description": "Esterified estrogens may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB11478",
                        "description": "Zeranol may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB11674",
                        "description": "Equol may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB12487",
                        "description": "Promestriene may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13143",
                        "description": "Methallenestril may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13386",
                        "description": "Epimestrol may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13418",
                        "description": "Moxestrol may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13952",
                        "description": "Estradiol acetate may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13953",
                        "description": "Estradiol benzoate may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13954",
                        "description": "Estradiol cypionate may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13956",
                        "description": "Estradiol valerate may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB15334",
                        "description": "Biochanin A may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB15335",
                        "description": "Formononetin may increase the thrombogenic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB01097",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Leflunomide"
                    },
                    {
                        "drugbank-id": "DB08895",
                        "description": "Trastuzumab may increase the immunosuppressive activities of Tofacitinib"
                    },
                    {
                        "drugbank-id": "DB00005",
                        "description": "Trastuzumab may increase the neutropenic activities of Etanercept"
                    },
                    {
                        "drugbank-id": "DB00074",
                        "description": "Trastuzumab may increase the neutropenic activities of Basiliximab"
                    },
                    {
                        "drugbank-id": "DB00075",
                        "description": "Trastuzumab may increase the neutropenic activities of Muromonab"
                    },
                    {
                        "drugbank-id": "DB00111",
                        "description": "Trastuzumab may increase the neutropenic activities of Daclizumab"
                    },
                    {
                        "drugbank-id": "DB00242",
                        "description": "Trastuzumab may increase the neutropenic activities of Cladribine"
                    },
                    {
                        "drugbank-id": "DB00688",
                        "description": "Trastuzumab may increase the neutropenic activities of Mycophenolate mofetil"
                    },
                    {
                        "drugbank-id": "DB00877",
                        "description": "Trastuzumab may increase the neutropenic activities of Sirolimus"
                    },
                    {
                        "drugbank-id": "DB00993",
                        "description": "Trastuzumab may increase the neutropenic activities of Azathioprine"
                    },
                    {
                        "drugbank-id": "DB01024",
                        "description": "Trastuzumab may increase the neutropenic activities of Mycophenolic acid"
                    },
                    {
                        "drugbank-id": "DB01041",
                        "description": "Trastuzumab may increase the neutropenic activities of Thalidomide"
                    },
                    {
                        "drugbank-id": "DB01281",
                        "description": "Trastuzumab may increase the neutropenic activities of Abatacept"
                    },
                    {
                        "drugbank-id": "DB01590",
                        "description": "Trastuzumab may increase the neutropenic activities of Everolimus"
                    },
                    {
                        "drugbank-id": "DB06681",
                        "description": "Trastuzumab may increase the neutropenic activities of Belatacept"
                    },
                    {
                        "drugbank-id": "DB08879",
                        "description": "Trastuzumab may increase the neutropenic activities of Belimumab"
                    },
                    {
                        "drugbank-id": "DB08880",
                        "description": "Trastuzumab may increase the neutropenic activities of Teriflunomide"
                    },
                    {
                        "drugbank-id": "DB08904",
                        "description": "Trastuzumab may increase the neutropenic activities of Certolizumab pegol"
                    },
                    {
                        "drugbank-id": "DB06168",
                        "description": "Trastuzumab may increase the neutropenic activities of Canakinumab"
                    },
                    {
                        "drugbank-id": "DB09033",
                        "description": "Trastuzumab may increase the neutropenic activities of Vedolizumab"
                    },
                    {
                        "drugbank-id": "DB09036",
                        "description": "Trastuzumab may increase the neutropenic activities of Siltuximab"
                    },
                    {
                        "drugbank-id": "DB12692",
                        "description": "Trastuzumab may increase the neutropenic activities of Gusperimus"
                    },
                    {
                        "drugbank-id": "DB11693",
                        "description": "Trastuzumab may increase the neutropenic activities of Voclosporin"
                    },
                    {
                        "drugbank-id": "DB09312",
                        "description": "Trastuzumab may increase the neutropenic activities of Antilymphocyte immunoglobulin horse"
                    },
                    {
                        "drugbank-id": "DB06612",
                        "description": "Trastuzumab may increase the neutropenic activities of Mepolizumab"
                    },
                    {
                        "drugbank-id": "DB00441",
                        "description": "Trastuzumab may increase the neutropenic activities of Gemcitabine"
                    },
                    {
                        "drugbank-id": "DB00531",
                        "description": "Trastuzumab may increase the neutropenic activities of Cyclophosphamide"
                    },
                    {
                        "drugbank-id": "DB00544",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluorouracil"
                    },
                    {
                        "drugbank-id": "DB00563",
                        "description": "Trastuzumab may increase the neutropenic activities of Methotrexate"
                    },
                    {
                        "drugbank-id": "DB00620",
                        "description": "Trastuzumab may increase the neutropenic activities of Triamcinolone"
                    },
                    {
                        "drugbank-id": "DB00987",
                        "description": "Trastuzumab may increase the neutropenic activities of Cytarabine"
                    },
                    {
                        "drugbank-id": "DB01008",
                        "description": "Trastuzumab may increase the neutropenic activities of Busulfan"
                    },
                    {
                        "drugbank-id": "DB01033",
                        "description": "Trastuzumab may increase the neutropenic activities of Mercaptopurine"
                    },
                    {
                        "drugbank-id": "DB01042",
                        "description": "Trastuzumab may increase the neutropenic activities of Melphalan"
                    },
                    {
                        "drugbank-id": "DB01073",
                        "description": "Trastuzumab may increase the neutropenic activities of Fludarabine"
                    },
                    {
                        "drugbank-id": "DB04572",
                        "description": "Trastuzumab may increase the neutropenic activities of Thiotepa"
                    },
                    {
                        "drugbank-id": "DB05259",
                        "description": "Trastuzumab may increase the neutropenic activities of Glatiramer"
                    },
                    {
                        "drugbank-id": "DB00026",
                        "description": "Trastuzumab may increase the neutropenic activities of Anakinra"
                    },
                    {
                        "drugbank-id": "DB00051",
                        "description": "Trastuzumab may increase the neutropenic activities of Adalimumab"
                    },
                    {
                        "drugbank-id": "DB00065",
                        "description": "Trastuzumab may increase the neutropenic activities of Infliximab"
                    },
                    {
                        "drugbank-id": "DB00087",
                        "description": "Trastuzumab may increase the neutropenic activities of Alemtuzumab"
                    },
                    {
                        "drugbank-id": "DB00098",
                        "description": "Trastuzumab may increase the neutropenic activities of Antithymocyte immunoglobulin rabbit"
                    },
                    {
                        "drugbank-id": "DB00480",
                        "description": "Trastuzumab may increase the neutropenic activities of Lenalidomide"
                    },
                    {
                        "drugbank-id": "DB01257",
                        "description": "Trastuzumab may increase the neutropenic activities of Eculizumab"
                    },
                    {
                        "drugbank-id": "DB06273",
                        "description": "Trastuzumab may increase the neutropenic activities of Tocilizumab"
                    },
                    {
                        "drugbank-id": "DB06372",
                        "description": "Trastuzumab may increase the neutropenic activities of Rilonacept"
                    },
                    {
                        "drugbank-id": "DB06674",
                        "description": "Trastuzumab may increase the neutropenic activities of Golimumab"
                    },
                    {
                        "drugbank-id": "DB08910",
                        "description": "Trastuzumab may increase the neutropenic activities of Pomalidomide"
                    },
                    {
                        "drugbank-id": "DB09029",
                        "description": "Trastuzumab may increase the neutropenic activities of Secukinumab"
                    },
                    {
                        "drugbank-id": "DB00056",
                        "description": "Trastuzumab may increase the neutropenic activities of Gemtuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB00059",
                        "description": "Trastuzumab may increase the neutropenic activities of Pegaspargase"
                    },
                    {
                        "drugbank-id": "DB00073",
                        "description": "Trastuzumab may increase the neutropenic activities of Rituximab"
                    },
                    {
                        "drugbank-id": "DB00078",
                        "description": "Trastuzumab may increase the neutropenic activities of Ibritumomab tiuxetan"
                    },
                    {
                        "drugbank-id": "DB00081",
                        "description": "Trastuzumab may increase the neutropenic activities of Tositumomab"
                    },
                    {
                        "drugbank-id": "DB00120",
                        "description": "Trastuzumab may increase the neutropenic activities of Phenylalanine"
                    },
                    {
                        "drugbank-id": "DB00262",
                        "description": "Trastuzumab may increase the neutropenic activities of Carmustine"
                    },
                    {
                        "drugbank-id": "DB00276",
                        "description": "Trastuzumab may increase the neutropenic activities of Amsacrine"
                    },
                    {
                        "drugbank-id": "DB00290",
                        "description": "Trastuzumab may increase the neutropenic activities of Bleomycin"
                    },
                    {
                        "drugbank-id": "DB00291",
                        "description": "Trastuzumab may increase the neutropenic activities of Chlorambucil"
                    },
                    {
                        "drugbank-id": "DB00305",
                        "description": "Trastuzumab may increase the neutropenic activities of Mitomycin"
                    },
                    {
                        "drugbank-id": "DB00309",
                        "description": "Trastuzumab may increase the neutropenic activities of Vindesine"
                    },
                    {
                        "drugbank-id": "DB00322",
                        "description": "Trastuzumab may increase the neutropenic activities of Floxuridine"
                    },
                    {
                        "drugbank-id": "DB00352",
                        "description": "Trastuzumab may increase the neutropenic activities of Tioguanine"
                    },
                    {
                        "drugbank-id": "DB00361",
                        "description": "Trastuzumab may increase the neutropenic activities of Vinorelbine"
                    },
                    {
                        "drugbank-id": "DB00398",
                        "description": "Trastuzumab may increase the neutropenic activities of Sorafenib"
                    },
                    {
                        "drugbank-id": "DB00428",
                        "description": "Trastuzumab may increase the neutropenic activities of Streptozocin"
                    },
                    {
                        "drugbank-id": "DB00443",
                        "description": "Trastuzumab may increase the neutropenic activities of Betamethasone"
                    },
                    {
                        "drugbank-id": "DB00444",
                        "description": "Trastuzumab may increase the neutropenic activities of Teniposide"
                    },
                    {
                        "drugbank-id": "DB00488",
                        "description": "Trastuzumab may increase the neutropenic activities of Altretamine"
                    },
                    {
                        "drugbank-id": "DB00515",
                        "description": "Trastuzumab may increase the neutropenic activities of Cisplatin"
                    },
                    {
                        "drugbank-id": "DB00526",
                        "description": "Trastuzumab may increase the neutropenic activities of Oxaliplatin"
                    },
                    {
                        "drugbank-id": "DB00541",
                        "description": "Trastuzumab may increase the neutropenic activities of Vincristine"
                    },
                    {
                        "drugbank-id": "DB00552",
                        "description": "Trastuzumab may increase the neutropenic activities of Pentostatin"
                    },
                    {
                        "drugbank-id": "DB00570",
                        "description": "Trastuzumab may increase the neutropenic activities of Vinblastine"
                    },
                    {
                        "drugbank-id": "DB00619",
                        "description": "Trastuzumab may increase the neutropenic activities of Imatinib"
                    },
                    {
                        "drugbank-id": "DB00631",
                        "description": "Trastuzumab may increase the neutropenic activities of Clofarabine"
                    },
                    {
                        "drugbank-id": "DB00635",
                        "description": "Trastuzumab may increase the neutropenic activities of Prednisone"
                    },
                    {
                        "drugbank-id": "DB00642",
                        "description": "Trastuzumab may increase the neutropenic activities of Pemetrexed"
                    },
                    {
                        "drugbank-id": "DB00687",
                        "description": "Trastuzumab may increase the neutropenic activities of Fludrocortisone"
                    },
                    {
                        "drugbank-id": "DB00724",
                        "description": "Trastuzumab may increase the neutropenic activities of Imiquimod"
                    },
                    {
                        "drugbank-id": "DB00741",
                        "description": "Trastuzumab may increase the neutropenic activities of Hydrocortisone"
                    },
                    {
                        "drugbank-id": "DB00755",
                        "description": "Trastuzumab may increase the neutropenic activities of Tretinoin"
                    },
                    {
                        "drugbank-id": "DB00762",
                        "description": "Trastuzumab may increase the neutropenic activities of Irinotecan"
                    },
                    {
                        "drugbank-id": "DB00773",
                        "description": "Trastuzumab may increase the neutropenic activities of Etoposide"
                    },
                    {
                        "drugbank-id": "DB00851",
                        "description": "Trastuzumab may increase the neutropenic activities of Dacarbazine"
                    },
                    {
                        "drugbank-id": "DB00853",
                        "description": "Trastuzumab may increase the neutropenic activities of Temozolomide"
                    },
                    {
                        "drugbank-id": "DB00860",
                        "description": "Trastuzumab may increase the neutropenic activities of Prednisolone"
                    },
                    {
                        "drugbank-id": "DB00888",
                        "description": "Trastuzumab may increase the neutropenic activities of Mechlorethamine"
                    },
                    {
                        "drugbank-id": "DB00928",
                        "description": "Trastuzumab may increase the neutropenic activities of Azacitidine"
                    },
                    {
                        "drugbank-id": "DB00958",
                        "description": "Trastuzumab may increase the neutropenic activities of Carboplatin"
                    },
                    {
                        "drugbank-id": "DB00959",
                        "description": "Trastuzumab may increase the neutropenic activities of Methylprednisolone"
                    },
                    {
                        "drugbank-id": "DB00970",
                        "description": "Trastuzumab may increase the neutropenic activities of Dactinomycin"
                    },
                    {
                        "drugbank-id": "DB01005",
                        "description": "Trastuzumab may increase the neutropenic activities of Hydroxyurea"
                    },
                    {
                        "drugbank-id": "DB01030",
                        "description": "Trastuzumab may increase the neutropenic activities of Topotecan"
                    },
                    {
                        "drugbank-id": "DB01101",
                        "description": "Trastuzumab may increase the neutropenic activities of Capecitabine"
                    },
                    {
                        "drugbank-id": "DB01168",
                        "description": "Trastuzumab may increase the neutropenic activities of Procarbazine"
                    },
                    {
                        "drugbank-id": "DB01181",
                        "description": "Trastuzumab may increase the neutropenic activities of Ifosfamide"
                    },
                    {
                        "drugbank-id": "DB01196",
                        "description": "Trastuzumab may increase the neutropenic activities of Estramustine"
                    },
                    {
                        "drugbank-id": "DB01204",
                        "description": "Trastuzumab may increase the neutropenic activities of Mitoxantrone"
                    },
                    {
                        "drugbank-id": "DB01206",
                        "description": "Trastuzumab may increase the neutropenic activities of Lomustine"
                    },
                    {
                        "drugbank-id": "DB01222",
                        "description": "Trastuzumab may increase the neutropenic activities of Budesonide"
                    },
                    {
                        "drugbank-id": "DB01234",
                        "description": "Trastuzumab may increase the neutropenic activities of Dexamethasone"
                    },
                    {
                        "drugbank-id": "DB01248",
                        "description": "Trastuzumab may increase the neutropenic activities of Docetaxel"
                    },
                    {
                        "drugbank-id": "DB01254",
                        "description": "Trastuzumab may increase the neutropenic activities of Dasatinib"
                    },
                    {
                        "drugbank-id": "DB01268",
                        "description": "Trastuzumab may increase the neutropenic activities of Sunitinib"
                    },
                    {
                        "drugbank-id": "DB01280",
                        "description": "Trastuzumab may increase the neutropenic activities of Nelarabine"
                    },
                    {
                        "drugbank-id": "DB01285",
                        "description": "Trastuzumab may increase the neutropenic activities of Corticotropin"
                    },
                    {
                        "drugbank-id": "DB01380",
                        "description": "Trastuzumab may increase the neutropenic activities of Cortisone acetate"
                    },
                    {
                        "drugbank-id": "DB04868",
                        "description": "Trastuzumab may increase the neutropenic activities of Nilotinib"
                    },
                    {
                        "drugbank-id": "DB05109",
                        "description": "Trastuzumab may increase the neutropenic activities of Trabectedin"
                    },
                    {
                        "drugbank-id": "DB05773",
                        "description": "Trastuzumab may increase the neutropenic activities of Trastuzumab emtansine"
                    },
                    {
                        "drugbank-id": "DB06287",
                        "description": "Trastuzumab may increase the neutropenic activities of Temsirolimus"
                    },
                    {
                        "drugbank-id": "DB06589",
                        "description": "Trastuzumab may increase the neutropenic activities of Pazopanib"
                    },
                    {
                        "drugbank-id": "DB06603",
                        "description": "Trastuzumab may increase the neutropenic activities of Panobinostat"
                    },
                    {
                        "drugbank-id": "DB06772",
                        "description": "Trastuzumab may increase the neutropenic activities of Cabazitaxel"
                    },
                    {
                        "drugbank-id": "DB06813",
                        "description": "Trastuzumab may increase the neutropenic activities of Pralatrexate"
                    },
                    {
                        "drugbank-id": "DB08870",
                        "description": "Trastuzumab may increase the neutropenic activities of Brentuximab vedotin"
                    },
                    {
                        "drugbank-id": "DB08877",
                        "description": "Trastuzumab may increase the neutropenic activities of Ruxolitinib"
                    },
                    {
                        "drugbank-id": "DB08935",
                        "description": "Trastuzumab may increase the neutropenic activities of Obinutuzumab"
                    },
                    {
                        "drugbank-id": "DB09052",
                        "description": "Trastuzumab may increase the neutropenic activities of Blinatumomab"
                    },
                    {
                        "drugbank-id": "DB09053",
                        "description": "Trastuzumab may increase the neutropenic activities of Ibrutinib"
                    },
                    {
                        "drugbank-id": "DB09054",
                        "description": "Trastuzumab may increase the neutropenic activities of Idelalisib"
                    },
                    {
                        "drugbank-id": "DB09073",
                        "description": "Trastuzumab may increase the neutropenic activities of Palbociclib"
                    },
                    {
                        "drugbank-id": "DB09077",
                        "description": "Trastuzumab may increase the neutropenic activities of Dinutuximab"
                    },
                    {
                        "drugbank-id": "DB09082",
                        "description": "Trastuzumab may increase the neutropenic activities of Vilanterol"
                    },
                    {
                        "drugbank-id": "DB01423",
                        "description": "Trastuzumab may increase the neutropenic activities of Stepronin"
                    },
                    {
                        "drugbank-id": "DB01816",
                        "description": "Trastuzumab may increase the neutropenic activities of Castanospermine"
                    },
                    {
                        "drugbank-id": "DB02806",
                        "description": "Trastuzumab may increase the neutropenic activities of 2 Methoxyethanol"
                    },
                    {
                        "drugbank-id": "DB05260",
                        "description": "Trastuzumab may increase the neutropenic activities of Gallium nitrate"
                    },
                    {
                        "drugbank-id": "DB08908",
                        "description": "Trastuzumab may increase the neutropenic activities of Dimethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB11921",
                        "description": "Trastuzumab may increase the neutropenic activities of Deflazacort"
                    },
                    {
                        "drugbank-id": "DB12025",
                        "description": "Trastuzumab may increase the neutropenic activities of Triptolide"
                    },
                    {
                        "drugbank-id": "DB12617",
                        "description": "Trastuzumab may increase the neutropenic activities of Mizoribine"
                    },
                    {
                        "drugbank-id": "DB12902",
                        "description": "Trastuzumab may increase the neutropenic activities of Trofosfamide"
                    },
                    {
                        "drugbank-id": "DB12947",
                        "description": "Trastuzumab may increase the neutropenic activities of Doxifluridine"
                    },
                    {
                        "drugbank-id": "DB12991",
                        "description": "Trastuzumab may increase the neutropenic activities of Deoxyspergualin"
                    },
                    {
                        "drugbank-id": "DB12996",
                        "description": "Trastuzumab may increase the neutropenic activities of Acteoside"
                    },
                    {
                        "drugbank-id": "DB13014",
                        "description": "Trastuzumab may increase the neutropenic activities of Hypericin"
                    },
                    {
                        "drugbank-id": "DB00092",
                        "description": "Trastuzumab may increase the neutropenic activities of Alefacept"
                    },
                    {
                        "drugbank-id": "DB00095",
                        "description": "Trastuzumab may increase the neutropenic activities of Efalizumab"
                    },
                    {
                        "drugbank-id": "DB04951",
                        "description": "Trastuzumab may increase the neutropenic activities of Pirfenidone"
                    },
                    {
                        "drugbank-id": "DB04956",
                        "description": "Trastuzumab may increase the neutropenic activities of Afelimomab"
                    },
                    {
                        "drugbank-id": "DB05676",
                        "description": "Trastuzumab may increase the neutropenic activities of Apremilast"
                    },
                    {
                        "drugbank-id": "DB06662",
                        "description": "Trastuzumab may increase the neutropenic activities of Abetimus"
                    },
                    {
                        "drugbank-id": "DB11776",
                        "description": "Trastuzumab may increase the neutropenic activities of Brodalumab"
                    },
                    {
                        "drugbank-id": "DB13241",
                        "description": "Trastuzumab may increase the neutropenic activities of Begelomab"
                    },
                    {
                        "drugbank-id": "DB08059",
                        "description": "Trastuzumab may increase the neutropenic activities of Wortmannin"
                    },
                    {
                        "drugbank-id": "DB13068",
                        "description": "Trastuzumab may increase the neutropenic activities of 9 N methyl L isoleucine cyclosporin A"
                    },
                    {
                        "drugbank-id": "DB00008",
                        "description": "Trastuzumab may increase the neutropenic activities of Peginterferon alfa 2a"
                    },
                    {
                        "drugbank-id": "DB00018",
                        "description": "Trastuzumab may increase the neutropenic activities of Interferon alfa n3"
                    },
                    {
                        "drugbank-id": "DB00022",
                        "description": "Trastuzumab may increase the neutropenic activities of Peginterferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB00041",
                        "description": "Trastuzumab may increase the neutropenic activities of Aldesleukin"
                    },
                    {
                        "drugbank-id": "DB00069",
                        "description": "Trastuzumab may increase the neutropenic activities of Interferon alfacon 1"
                    },
                    {
                        "drugbank-id": "DB00112",
                        "description": "Trastuzumab may increase the neutropenic activities of Bevacizumab"
                    },
                    {
                        "drugbank-id": "DB00188",
                        "description": "Trastuzumab may increase the neutropenic activities of Bortezomib"
                    },
                    {
                        "drugbank-id": "DB00293",
                        "description": "Trastuzumab may increase the neutropenic activities of Raltitrexed"
                    },
                    {
                        "drugbank-id": "DB00307",
                        "description": "Trastuzumab may increase the neutropenic activities of Bexarotene"
                    },
                    {
                        "drugbank-id": "DB00380",
                        "description": "Trastuzumab may increase the neutropenic activities of Dexrazoxane"
                    },
                    {
                        "drugbank-id": "DB00446",
                        "description": "Trastuzumab may increase the neutropenic activities of Chloramphenicol"
                    },
                    {
                        "drugbank-id": "DB00495",
                        "description": "Trastuzumab may increase the neutropenic activities of Zidovudine"
                    },
                    {
                        "drugbank-id": "DB00550",
                        "description": "Trastuzumab may increase the neutropenic activities of Propylthiouracil"
                    },
                    {
                        "drugbank-id": "DB00564",
                        "description": "Trastuzumab may increase the neutropenic activities of Carbamazepine"
                    },
                    {
                        "drugbank-id": "DB00601",
                        "description": "Trastuzumab may increase the neutropenic activities of Linezolid"
                    },
                    {
                        "drugbank-id": "DB00763",
                        "description": "Trastuzumab may increase the neutropenic activities of Methimazole"
                    },
                    {
                        "drugbank-id": "DB01099",
                        "description": "Trastuzumab may increase the neutropenic activities of Flucytosine"
                    },
                    {
                        "drugbank-id": "DB01169",
                        "description": "Trastuzumab may increase the neutropenic activities of Arsenic trioxide"
                    },
                    {
                        "drugbank-id": "DB01262",
                        "description": "Trastuzumab may increase the neutropenic activities of Decitabine"
                    },
                    {
                        "drugbank-id": "DB02546",
                        "description": "Trastuzumab may increase the neutropenic activities of Vorinostat"
                    },
                    {
                        "drugbank-id": "DB04845",
                        "description": "Trastuzumab may increase the neutropenic activities of Ixabepilone"
                    },
                    {
                        "drugbank-id": "DB05015",
                        "description": "Trastuzumab may increase the neutropenic activities of Belinostat"
                    },
                    {
                        "drugbank-id": "DB06616",
                        "description": "Trastuzumab may increase the neutropenic activities of Bosutinib"
                    },
                    {
                        "drugbank-id": "DB06769",
                        "description": "Trastuzumab may increase the neutropenic activities of Bendamustine"
                    },
                    {
                        "drugbank-id": "DB08871",
                        "description": "Trastuzumab may increase the neutropenic activities of Eribulin"
                    },
                    {
                        "drugbank-id": "DB08889",
                        "description": "Trastuzumab may increase the neutropenic activities of Carfilzomib"
                    },
                    {
                        "drugbank-id": "DB08901",
                        "description": "Trastuzumab may increase the neutropenic activities of Ponatinib"
                    },
                    {
                        "drugbank-id": "DB09074",
                        "description": "Trastuzumab may increase the neutropenic activities of Olaparib"
                    },
                    {
                        "drugbank-id": "DB11767",
                        "description": "Trastuzumab may increase the neutropenic activities of Sarilumab"
                    },
                    {
                        "drugbank-id": "DB05459",
                        "description": "Trastuzumab may increase the neutropenic activities of Briakinumab"
                    },
                    {
                        "drugbank-id": "DB11466",
                        "description": "Trastuzumab may increase the neutropenic activities of Tepoxalin"
                    },
                    {
                        "drugbank-id": "DB14066",
                        "description": "Trastuzumab may increase the neutropenic activities of Tetrandrine"
                    },
                    {
                        "drugbank-id": "DB00795",
                        "description": "Trastuzumab may increase the neutropenic activities of Sulfasalazine"
                    },
                    {
                        "drugbank-id": "DB01611",
                        "description": "Trastuzumab may increase the neutropenic activities of Hydroxychloroquine"
                    },
                    {
                        "drugbank-id": "DB00432",
                        "description": "Trastuzumab may increase the neutropenic activities of Trifluridine"
                    },
                    {
                        "drugbank-id": "DB04630",
                        "description": "Trastuzumab may increase the neutropenic activities of Aldosterone"
                    },
                    {
                        "drugbank-id": "DB01108",
                        "description": "Trastuzumab may increase the neutropenic activities of Trilostane"
                    },
                    {
                        "drugbank-id": "DB13208",
                        "description": "Trastuzumab may increase the neutropenic activities of Prednylidene"
                    },
                    {
                        "drugbank-id": "DB01384",
                        "description": "Trastuzumab may increase the neutropenic activities of Paramethasone"
                    },
                    {
                        "drugbank-id": "DB09383",
                        "description": "Trastuzumab may increase the neutropenic activities of Meprednisone"
                    },
                    {
                        "drugbank-id": "DB11529",
                        "description": "Trastuzumab may increase the neutropenic activities of Melengestrol"
                    },
                    {
                        "drugbank-id": "DB09378",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluprednisolone"
                    },
                    {
                        "drugbank-id": "DB00180",
                        "description": "Trastuzumab may increase the neutropenic activities of Flunisolide"
                    },
                    {
                        "drugbank-id": "DB13003",
                        "description": "Trastuzumab may increase the neutropenic activities of Cortivazol"
                    },
                    {
                        "drugbank-id": "DB13843",
                        "description": "Trastuzumab may increase the neutropenic activities of Cloprednol"
                    },
                    {
                        "drugbank-id": "DB00240",
                        "description": "Trastuzumab may increase the neutropenic activities of Alclometasone"
                    },
                    {
                        "drugbank-id": "DB00288",
                        "description": "Trastuzumab may increase the neutropenic activities of Amcinonide"
                    },
                    {
                        "drugbank-id": "DB01410",
                        "description": "Trastuzumab may increase the neutropenic activities of Ciclesonide"
                    },
                    {
                        "drugbank-id": "DB11750",
                        "description": "Trastuzumab may increase the neutropenic activities of Clobetasol"
                    },
                    {
                        "drugbank-id": "DB01013",
                        "description": "Trastuzumab may increase the neutropenic activities of Clobetasol propionate"
                    },
                    {
                        "drugbank-id": "DB13158",
                        "description": "Trastuzumab may increase the neutropenic activities of Clobetasone"
                    },
                    {
                        "drugbank-id": "DB00838",
                        "description": "Trastuzumab may increase the neutropenic activities of Clocortolone"
                    },
                    {
                        "drugbank-id": "DB01260",
                        "description": "Trastuzumab may increase the neutropenic activities of Desonide"
                    },
                    {
                        "drugbank-id": "DB00547",
                        "description": "Trastuzumab may increase the neutropenic activities of Desoximetasone"
                    },
                    {
                        "drugbank-id": "DB11487",
                        "description": "Trastuzumab may increase the neutropenic activities of Dexamethasone isonicotinate"
                    },
                    {
                        "drugbank-id": "DB00223",
                        "description": "Trastuzumab may increase the neutropenic activities of Diflorasone"
                    },
                    {
                        "drugbank-id": "DB09095",
                        "description": "Trastuzumab may increase the neutropenic activities of Difluocortolone"
                    },
                    {
                        "drugbank-id": "DB06781",
                        "description": "Trastuzumab may increase the neutropenic activities of Difluprednate"
                    },
                    {
                        "drugbank-id": "DB13856",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluclorolone"
                    },
                    {
                        "drugbank-id": "DB00663",
                        "description": "Trastuzumab may increase the neutropenic activities of Flumethasone"
                    },
                    {
                        "drugbank-id": "DB00591",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluocinolone acetonide"
                    },
                    {
                        "drugbank-id": "DB01047",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluocinonide"
                    },
                    {
                        "drugbank-id": "DB13223",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluocortin"
                    },
                    {
                        "drugbank-id": "DB08971",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluocortolone"
                    },
                    {
                        "drugbank-id": "DB00324",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluorometholone"
                    },
                    {
                        "drugbank-id": "DB13491",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluperolone"
                    },
                    {
                        "drugbank-id": "DB08970",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluprednidene"
                    },
                    {
                        "drugbank-id": "DB00846",
                        "description": "Trastuzumab may increase the neutropenic activities of Flurandrenolide"
                    },
                    {
                        "drugbank-id": "DB13867",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluticasone"
                    },
                    {
                        "drugbank-id": "DB08906",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluticasone furoate"
                    },
                    {
                        "drugbank-id": "DB00588",
                        "description": "Trastuzumab may increase the neutropenic activities of Fluticasone propionate"
                    },
                    {
                        "drugbank-id": "DB13664",
                        "description": "Trastuzumab may increase the neutropenic activities of Formocortal"
                    },
                    {
                        "drugbank-id": "DB06786",
                        "description": "Trastuzumab may increase the neutropenic activities of Halcinonide"
                    },
                    {
                        "drugbank-id": "DB13728",
                        "description": "Trastuzumab may increase the neutropenic activities of Halometasone"
                    },
                    {
                        "drugbank-id": "DB14538",
                        "description": "Trastuzumab may increase the neutropenic activities of Hydrocortisone aceponate"
                    },
                    {
                        "drugbank-id": "DB14539",
                        "description": "Trastuzumab may increase the neutropenic activities of Hydrocortisone acetate"
                    },
                    {
                        "drugbank-id": "DB14543",
                        "description": "Trastuzumab may increase the neutropenic activities of Hydrocortisone probutate"
                    },
                    {
                        "drugbank-id": "DB14540",
                        "description": "Trastuzumab may increase the neutropenic activities of Hydrocortisone butyrate"
                    },
                    {
                        "drugbank-id": "DB14545",
                        "description": "Trastuzumab may increase the neutropenic activities of Hydrocortisone succinate"
                    },
                    {
                        "drugbank-id": "DB14544",
                        "description": "Trastuzumab may increase the neutropenic activities of Hydrocortisone valerate"
                    },
                    {
                        "drugbank-id": "DB00253",
                        "description": "Trastuzumab may increase the neutropenic activities of Medrysone"
                    },
                    {
                        "drugbank-id": "DB00764",
                        "description": "Trastuzumab may increase the neutropenic activities of Mometasone"
                    },
                    {
                        "drugbank-id": "DB14512",
                        "description": "Trastuzumab may increase the neutropenic activities of Mometasone furoate"
                    },
                    {
                        "drugbank-id": "DB01130",
                        "description": "Trastuzumab may increase the neutropenic activities of Prednicarbate"
                    },
                    {
                        "drugbank-id": "DB00896",
                        "description": "Trastuzumab may increase the neutropenic activities of Rimexolone"
                    },
                    {
                        "drugbank-id": "DB09091",
                        "description": "Trastuzumab may increase the neutropenic activities of Tixocortol"
                    },
                    {
                        "drugbank-id": "DB00596",
                        "description": "Trastuzumab may increase the neutropenic activities of Ulobetasol"
                    },
                    {
                        "drugbank-id": "DB01394",
                        "description": "Trastuzumab may increase the neutropenic activities of Colchicine"
                    },
                    {
                        "drugbank-id": "DB14219",
                        "description": "Trastuzumab may increase the neutropenic activities of Monomethyl fumarate"
                    },
                    {
                        "drugbank-id": "DB00859",
                        "description": "Trastuzumab may increase the neutropenic activities of Penicillamine"
                    },
                    {
                        "drugbank-id": "DB00328",
                        "description": "Trastuzumab may increase the neutropenic activities of Indomethacin"
                    },
                    {
                        "drugbank-id": "DB03523",
                        "description": "Trastuzumab may increase the neutropenic activities of Brequinar"
                    },
                    {
                        "drugbank-id": "DB00033",
                        "description": "Trastuzumab may increase the neutropenic activities of Interferon gamma 1b"
                    },
                    {
                        "drugbank-id": "DB05472",
                        "description": "Trastuzumab may increase the neutropenic activities of Human interferon omega 1"
                    },
                    {
                        "drugbank-id": "DB00011",
                        "description": "Trastuzumab may increase the neutropenic activities of Interferon alfa n1"
                    },
                    {
                        "drugbank-id": "DB09122",
                        "description": "Trastuzumab may increase the neutropenic activities of Peginterferon beta 1a"
                    },
                    {
                        "drugbank-id": "DB12814",
                        "description": "Trastuzumab may increase the neutropenic activities of Cepeginterferon alfa 2B"
                    },
                    {
                        "drugbank-id": "DB00068",
                        "description": "Trastuzumab may increase the neutropenic activities of Interferon beta 1b"
                    },
                    {
                        "drugbank-id": "DB00034",
                        "description": "Trastuzumab may increase the neutropenic activities of Interferon alfa 2a Recombinant"
                    },
                    {
                        "drugbank-id": "DB05258",
                        "description": "Trastuzumab may increase the neutropenic activities of Interferon alfa"
                    },
                    {
                        "drugbank-id": "DB00105",
                        "description": "Trastuzumab may increase the neutropenic activities of Interferon alfa 2b"
                    },
                    {
                        "drugbank-id": "DB11569",
                        "description": "Trastuzumab may increase the neutropenic activities of Ixekizumab"
                    },
                    {
                        "drugbank-id": "DB11803",
                        "description": "Trastuzumab may increase the neutropenic activities of Sirukumab"
                    },
                    {
                        "drugbank-id": "DB11817",
                        "description": "Trastuzumab may increase the neutropenic activities of Baricitinib"
                    },
                    {
                        "drugbank-id": "DB11834",
                        "description": "Trastuzumab may increase the neutropenic activities of Guselkumab"
                    },
                    {
                        "drugbank-id": "DB12612",
                        "description": "Trastuzumab may increase the neutropenic activities of Ozanimod"
                    },
                    {
                        "drugbank-id": "DB14724",
                        "description": "Trastuzumab may increase the neutropenic activities of Emapalumab"
                    },
                    {
                        "drugbank-id": "DB12371",
                        "description": "Trastuzumab may increase the neutropenic activities of Siponimod"
                    },
                    {
                        "drugbank-id": "DB14762",
                        "description": "Trastuzumab may increase the neutropenic activities of Risankizumab"
                    },
                    {
                        "drugbank-id": "DB15253",
                        "description": "Trastuzumab may increase the neutropenic activities of Bleselumab"
                    },
                    {
                        "drugbank-id": "DB00394",
                        "description": "Trastuzumab may increase the neutropenic activities of Beclomethasone dipropionate"
                    },
                    {
                        "drugbank-id": "DB11580",
                        "description": "Trastuzumab may increase the neutropenic activities of Ravulizumab"
                    },
                    {
                        "drugbank-id": "DB11708",
                        "description": "Trastuzumab may increase the neutropenic activities of Peficitinib"
                    },
                    {
                        "drugbank-id": "DB14919",
                        "description": "Trastuzumab may increase the neutropenic activities of Rozanolixizumab"
                    },
                    {
                        "drugbank-id": "DB08868",
                        "description": "Trastuzumab may increase the immunosuppressive activities of Fingolimod"
                    },
                    {
                        "drugbank-id": "DB00864",
                        "description": "Tacrolimus may increase the immunosuppressive activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00390",
                        "description": "Digoxin may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00511",
                        "description": "Acetyldigitoxin may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB01078",
                        "description": "Deslanoside may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB01092",
                        "description": "Ouabain may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB01396",
                        "description": "Digitoxin may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB12843",
                        "description": "Oleandrin may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13240",
                        "description": "Cymarin may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13307",
                        "description": "Proscillaridin may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13401",
                        "description": "Metildigoxin may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13467",
                        "description": "Lanatoside C may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13537",
                        "description": "Gitoformate may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13691",
                        "description": "Acetyldigoxin may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13756",
                        "description": "Peruvoside may decrease the cardiotoxic activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00675",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Tamoxifen"
                    },
                    {
                        "drugbank-id": "DB01217",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Anastrozole"
                    },
                    {
                        "drugbank-id": "DB06171",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Paclitaxel trevatide"
                    },
                    {
                        "drugbank-id": "DB13809",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Paclitaxel poliglumex"
                    },
                    {
                        "drugbank-id": "DB04914",
                        "description": "The therapeutic efficacy of G17DT can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB05144",
                        "description": "The therapeutic efficacy of PEV3A can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB05325",
                        "description": "The therapeutic efficacy of INGN 225 can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB05374",
                        "description": "The therapeutic efficacy of Rindopepimut can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB05440",
                        "description": "The therapeutic efficacy of SRP 299 can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB05942",
                        "description": "The therapeutic efficacy of GI 5005 can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB06400",
                        "description": "The therapeutic efficacy of Vitespen can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB06584",
                        "description": "The therapeutic efficacy of TG4010 can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB09057",
                        "description": "The therapeutic efficacy of Anthrax immune globulin human can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10062",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen B can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10076",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 1482 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10276",
                        "description": "The therapeutic efficacy of Rotavirus vaccine can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10283",
                        "description": "The therapeutic efficacy of Rabies virus inactivated antigen A can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10342",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B capsular polysaccharide meningococcal outer membrane protein conjugate antigen can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10583",
                        "description": "The therapeutic efficacy of Clostridium tetani toxoid antigen formaldehyde inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10584",
                        "description": "The therapeutic efficacy of Corynebacterium diphtheriae toxoid antigen formaldehyde inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10600",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10769",
                        "description": "The therapeutic efficacy of Japanese encephalitis virus strain sa 14 14 2 antigen formaldehyde inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10794",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen formaldehyde inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10803",
                        "description": "The therapeutic efficacy of Typhoid Vi polysaccharide vaccine can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10989",
                        "description": "The therapeutic efficacy of Hepatitis A Vaccine can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10990",
                        "description": "The therapeutic efficacy of Haemophilus influenzae type B strain 20752 capsular polysaccharide tetanus toxoid conjugate antigen can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB11038",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB11040",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB11041",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 X 181 H1N1 hemagglutinin antigen propiolactone inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB11044",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 antigen propiolactone inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB11603",
                        "description": "The therapeutic efficacy of Human rabies virus immune globulin can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB11627",
                        "description": "The therapeutic efficacy of Hepatitis B Vaccine Recombinant can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB12568",
                        "description": "The therapeutic efficacy of Tecemotide can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14022",
                        "description": "The therapeutic efficacy of Typhoid vaccine can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14384",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14385",
                        "description": "The therapeutic efficacy of Influenza B virus B Brisbane 60 2008 hemagglutinin antigen formaldehyde inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14394",
                        "description": "The therapeutic efficacy of Influenza A virus A California 7 2009 H1N1 live attenuated antigen can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14445",
                        "description": "The therapeutic efficacy of Influenza A virus A Victoria 210 2009 X 187 H3N2 antigen formaldehyde inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14449",
                        "description": "The therapeutic efficacy of Influenza A virus A Perth 16 2009 H3N2 live attenuated antigen can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14619",
                        "description": "The therapeutic efficacy of Influenza A virus A Uruguay 716 2007 H3N2 antigen propiolactone inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14620",
                        "description": "The therapeutic efficacy of Influenza A virus A Brisbane 59 2007 H1N1 antigen propiolactone inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14711",
                        "description": "The therapeutic efficacy of Smallpox Vaccinia Vaccine Live can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB15274",
                        "description": "The therapeutic efficacy of Pertussis vaccine can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB15461",
                        "description": "The therapeutic efficacy of Yersinia pestis 195 p antigen formaldehyde inactivated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB13924",
                        "description": "The therapeutic efficacy of Varicella Zoster Vaccine Recombinant can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB15483",
                        "description": "The therapeutic efficacy of Modified vaccinia ankara can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB15654",
                        "description": "The therapeutic efficacy of Moderna COVID 19 Vaccine can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB11988",
                        "description": "Ocrelizumab may increase the immunosuppressive activities of Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10317",
                        "description": "The risk or severity of infection can be increased when Rubella virus vaccine is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10318",
                        "description": "The risk or severity of infection can be increased when Varicella Zoster Vaccine Live attenuated is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10343",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain tice live antigen is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10804",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain connaught live antigen is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB10805",
                        "description": "The risk or severity of infection can be increased when Yellow Fever Vaccine is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB11003",
                        "description": "The risk or severity of infection can be increased when Anthrax vaccine is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB11050",
                        "description": "The risk or severity of infection can be increased when Typhoid Vaccine Live is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB12386",
                        "description": "The risk or severity of infection can be increased when Bacillus calmette guerin substrain danish 1331 live antigen is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB12768",
                        "description": "The risk or severity of infection can be increased when BCG vaccine is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14409",
                        "description": "The risk or severity of infection can be increased when Human adenovirus e serotype 4 strain cl 68578 antigen is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14443",
                        "description": "The risk or severity of infection can be increased when Vibrio cholerae CVD 103 HgR strain live antigen is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14685",
                        "description": "The risk or severity of infection can be increased when Adenovirus type 7 vaccine live is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00002",
                        "description": "The risk or severity of adverse effects can be increased when Cetuximab is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00028",
                        "description": "The risk or severity of adverse effects can be increased when Human immunoglobulin G is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00043",
                        "description": "The risk or severity of adverse effects can be increased when Omalizumab is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00054",
                        "description": "The risk or severity of adverse effects can be increased when Abciximab is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00057",
                        "description": "The risk or severity of adverse effects can be increased when Indium In 111 satumomab pendetide is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB00076",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Digoxin Immune Fab Ovine"
                    },
                    {
                        "drugbank-id": "DB00089",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Capromab pendetide"
                    },
                    {
                        "drugbank-id": "DB00110",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Palivizumab"
                    },
                    {
                        "drugbank-id": "DB00113",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Technetium Tc 99m arcitumomab"
                    },
                    {
                        "drugbank-id": "DB01269",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Panitumumab"
                    },
                    {
                        "drugbank-id": "DB01270",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ranibizumab"
                    },
                    {
                        "drugbank-id": "DB04901",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Galiximab"
                    },
                    {
                        "drugbank-id": "DB04949",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Pexelizumab"
                    },
                    {
                        "drugbank-id": "DB04958",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Epratuzumab"
                    },
                    {
                        "drugbank-id": "DB04962",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Bectumomab"
                    },
                    {
                        "drugbank-id": "DB04964",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Oregovomab"
                    },
                    {
                        "drugbank-id": "DB04988",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with IGN311"
                    },
                    {
                        "drugbank-id": "DB05006",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Adecatumumab"
                    },
                    {
                        "drugbank-id": "DB05097",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Labetuzumab"
                    },
                    {
                        "drugbank-id": "DB05101",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Matuzumab"
                    },
                    {
                        "drugbank-id": "DB05111",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Fontolizumab"
                    },
                    {
                        "drugbank-id": "DB05136",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Bavituximab"
                    },
                    {
                        "drugbank-id": "DB05139",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with CR002"
                    },
                    {
                        "drugbank-id": "DB05209",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Rozrolimupab"
                    },
                    {
                        "drugbank-id": "DB05304",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Girentuximab"
                    },
                    {
                        "drugbank-id": "DB05336",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Obiltoxaximab"
                    },
                    {
                        "drugbank-id": "DB05405",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with XTL 001"
                    },
                    {
                        "drugbank-id": "DB05437",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with NAV 1800"
                    },
                    {
                        "drugbank-id": "DB05496",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Otelixizumab"
                    },
                    {
                        "drugbank-id": "DB05545",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with AMG 108"
                    },
                    {
                        "drugbank-id": "DB05550",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Iratumumab"
                    },
                    {
                        "drugbank-id": "DB05555",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Enokizumab"
                    },
                    {
                        "drugbank-id": "DB05578",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ramucirumab"
                    },
                    {
                        "drugbank-id": "DB05595",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Farletuzumab"
                    },
                    {
                        "drugbank-id": "DB05656",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Veltuzumab"
                    },
                    {
                        "drugbank-id": "DB05793",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with PRO 542"
                    },
                    {
                        "drugbank-id": "DB05797",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with TNX 901"
                    },
                    {
                        "drugbank-id": "DB05889",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Inotuzumab ozogamicin"
                    },
                    {
                        "drugbank-id": "DB05892",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with RI 624"
                    },
                    {
                        "drugbank-id": "DB05915",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with MYO 029"
                    },
                    {
                        "drugbank-id": "DB05916",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with CT 011"
                    },
                    {
                        "drugbank-id": "DB05941",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Leronlimab"
                    },
                    {
                        "drugbank-id": "DB05996",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Glembatumumab vedotin"
                    },
                    {
                        "drugbank-id": "DB06043",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Olaratumab"
                    },
                    {
                        "drugbank-id": "DB06049",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with IPH 2101"
                    },
                    {
                        "drugbank-id": "DB06050",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with TB 402"
                    },
                    {
                        "drugbank-id": "DB06081",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Caplacizumab"
                    },
                    {
                        "drugbank-id": "DB06101",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with IMC 1C11"
                    },
                    {
                        "drugbank-id": "DB06116",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Eldelumab"
                    },
                    {
                        "drugbank-id": "DB06162",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lumiliximab"
                    },
                    {
                        "drugbank-id": "DB06186",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ipilimumab"
                    },
                    {
                        "drugbank-id": "DB06192",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Nimotuzumab"
                    },
                    {
                        "drugbank-id": "DB06241",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Clenoliximab"
                    },
                    {
                        "drugbank-id": "DB06304",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with BIIB015"
                    },
                    {
                        "drugbank-id": "DB06305",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Sonepcizumab"
                    },
                    {
                        "drugbank-id": "DB06310",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Motavizumab"
                    },
                    {
                        "drugbank-id": "DB06317",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Elotuzumab"
                    },
                    {
                        "drugbank-id": "DB06318",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with AVE9633"
                    },
                    {
                        "drugbank-id": "DB06322",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Carotuximab"
                    },
                    {
                        "drugbank-id": "DB06324",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with XmAb 2513"
                    },
                    {
                        "drugbank-id": "DB06342",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Coltuximab ravtansine"
                    },
                    {
                        "drugbank-id": "DB06343",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Teprotumumab"
                    },
                    {
                        "drugbank-id": "DB06360",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lucatumumab"
                    },
                    {
                        "drugbank-id": "DB06371",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Siplizumab"
                    },
                    {
                        "drugbank-id": "DB06467",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Apolizumab"
                    },
                    {
                        "drugbank-id": "DB06474",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Sibrotuzumab"
                    },
                    {
                        "drugbank-id": "DB06550",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Bivatuzumab"
                    },
                    {
                        "drugbank-id": "DB06557",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lerdelimumab"
                    },
                    {
                        "drugbank-id": "DB06599",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lexatumumab"
                    },
                    {
                        "drugbank-id": "DB06602",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Reslizumab"
                    },
                    {
                        "drugbank-id": "DB06606",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Teplizumab"
                    },
                    {
                        "drugbank-id": "DB06607",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Catumaxomab"
                    },
                    {
                        "drugbank-id": "DB06647",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Volociximab"
                    },
                    {
                        "drugbank-id": "DB06650",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ofatumumab"
                    },
                    {
                        "drugbank-id": "DB08902",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Raxibacumab"
                    },
                    {
                        "drugbank-id": "DB09035",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Nivolumab"
                    },
                    {
                        "drugbank-id": "DB09037",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Pembrolizumab"
                    },
                    {
                        "drugbank-id": "DB09045",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Dulaglutide"
                    },
                    {
                        "drugbank-id": "DB09105",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Asfotase alfa"
                    },
                    {
                        "drugbank-id": "DB09264",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Idarucizumab"
                    },
                    {
                        "drugbank-id": "DB09302",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Alirocumab"
                    },
                    {
                        "drugbank-id": "DB09303",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Evolocumab"
                    },
                    {
                        "drugbank-id": "DB09331",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Daratumumab"
                    },
                    {
                        "drugbank-id": "DB09559",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Necitumumab"
                    },
                    {
                        "drugbank-id": "DB11595",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Atezolizumab"
                    },
                    {
                        "drugbank-id": "DB11604",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tetanus Immune Globulin"
                    },
                    {
                        "drugbank-id": "DB11608",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Eftrenonacog alfa"
                    },
                    {
                        "drugbank-id": "DB11621",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Human Varicella Zoster Immune Globulin"
                    },
                    {
                        "drugbank-id": "DB11646",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Conatumumab"
                    },
                    {
                        "drugbank-id": "DB11657",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tabalumab"
                    },
                    {
                        "drugbank-id": "DB11680",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ficlatuzumab"
                    },
                    {
                        "drugbank-id": "DB11685",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Figitumumab"
                    },
                    {
                        "drugbank-id": "DB11714",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Durvalumab"
                    },
                    {
                        "drugbank-id": "DB11715",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Bapineuzumab"
                    },
                    {
                        "drugbank-id": "DB11731",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Depatuxizumab mafodotin"
                    },
                    {
                        "drugbank-id": "DB11746",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Onartuzumab"
                    },
                    {
                        "drugbank-id": "DB11756",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Solanezumab"
                    },
                    {
                        "drugbank-id": "DB11771",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tremelimumab"
                    },
                    {
                        "drugbank-id": "DB11826",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lampalizumab"
                    },
                    {
                        "drugbank-id": "DB11840",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Dalotuzumab"
                    },
                    {
                        "drugbank-id": "DB11849",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Emibetuzumab"
                    },
                    {
                        "drugbank-id": "DB11850",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ublituximab"
                    },
                    {
                        "drugbank-id": "DB11856",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ligelizumab"
                    },
                    {
                        "drugbank-id": "DB11857",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Seribantumab"
                    },
                    {
                        "drugbank-id": "DB11862",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Landogrozumab"
                    },
                    {
                        "drugbank-id": "DB11866",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Romosozumab"
                    },
                    {
                        "drugbank-id": "DB11884",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Vadastuximab Talirine"
                    },
                    {
                        "drugbank-id": "DB11914",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lebrikizumab"
                    },
                    {
                        "drugbank-id": "DB11930",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Varlilumab"
                    },
                    {
                        "drugbank-id": "DB11945",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Avelumab"
                    },
                    {
                        "drugbank-id": "DB11959",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Crenezumab"
                    },
                    {
                        "drugbank-id": "DB11972",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Rilotumumab"
                    },
                    {
                        "drugbank-id": "DB11976",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Anifrolumab"
                    },
                    {
                        "drugbank-id": "DB12023",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Benralizumab"
                    },
                    {
                        "drugbank-id": "DB12034",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Gantenerumab"
                    },
                    {
                        "drugbank-id": "DB12053",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Visilizumab"
                    },
                    {
                        "drugbank-id": "DB12077",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Urelumab"
                    },
                    {
                        "drugbank-id": "DB12089",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lorvotuzumab mertansine"
                    },
                    {
                        "drugbank-id": "DB12090",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Patritumab"
                    },
                    {
                        "drugbank-id": "DB12102",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Fulranumab"
                    },
                    {
                        "drugbank-id": "DB12104",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tarextumab"
                    },
                    {
                        "drugbank-id": "DB12118",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Sotatercept"
                    },
                    {
                        "drugbank-id": "DB12119",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Gevokizumab"
                    },
                    {
                        "drugbank-id": "DB12142",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Duligotuzumab"
                    },
                    {
                        "drugbank-id": "DB12152",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Simtuzumab"
                    },
                    {
                        "drugbank-id": "DB12157",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Fasinumab"
                    },
                    {
                        "drugbank-id": "DB12159",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Dupilumab"
                    },
                    {
                        "drugbank-id": "DB12169",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tralokinumab"
                    },
                    {
                        "drugbank-id": "DB12189",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Etrolizumab"
                    },
                    {
                        "drugbank-id": "DB12202",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Zalutumumab"
                    },
                    {
                        "drugbank-id": "DB12205",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ganitumab"
                    },
                    {
                        "drugbank-id": "DB12213",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Etaracizumab"
                    },
                    {
                        "drugbank-id": "DB12240",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Polatuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB12246",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Inclacumab"
                    },
                    {
                        "drugbank-id": "DB12250",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Cixutumumab"
                    },
                    {
                        "drugbank-id": "DB12261",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ascrinvacumab"
                    },
                    {
                        "drugbank-id": "DB12274",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Aducanumab"
                    },
                    {
                        "drugbank-id": "DB12281",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Luspatercept"
                    },
                    {
                        "drugbank-id": "DB12296",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with GS 5745"
                    },
                    {
                        "drugbank-id": "DB12317",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Vanucizumab"
                    },
                    {
                        "drugbank-id": "DB12331",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Labetuzumab govitecan"
                    },
                    {
                        "drugbank-id": "DB12335",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tanezumab"
                    },
                    {
                        "drugbank-id": "DB12342",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ensituximab"
                    },
                    {
                        "drugbank-id": "DB12344",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Fezakinumab"
                    },
                    {
                        "drugbank-id": "DB12363",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Dusigitumab"
                    },
                    {
                        "drugbank-id": "DB12396",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Fresolimumab"
                    },
                    {
                        "drugbank-id": "DB12413",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Indusatumab vedotin"
                    },
                    {
                        "drugbank-id": "DB12456",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Bococizumab"
                    },
                    {
                        "drugbank-id": "DB12489",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Mirvetuximab Soravtansine"
                    },
                    {
                        "drugbank-id": "DB12498",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Mogamulizumab"
                    },
                    {
                        "drugbank-id": "DB12520",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Plozalizumab"
                    },
                    {
                        "drugbank-id": "DB12534",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Mavrilimumab"
                    },
                    {
                        "drugbank-id": "DB12560",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Blosozumab"
                    },
                    {
                        "drugbank-id": "DB12584",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Bimagrumab"
                    },
                    {
                        "drugbank-id": "DB12589",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Dacetuzumab"
                    },
                    {
                        "drugbank-id": "DB12609",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tovetumab"
                    },
                    {
                        "drugbank-id": "DB12683",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lumretuzumab"
                    },
                    {
                        "drugbank-id": "DB12698",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ibalizumab"
                    },
                    {
                        "drugbank-id": "DB12701",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Intetumumab"
                    },
                    {
                        "drugbank-id": "DB12718",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Carlumab"
                    },
                    {
                        "drugbank-id": "DB12734",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Demcizumab"
                    },
                    {
                        "drugbank-id": "DB12773",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Sifalimumab"
                    },
                    {
                        "drugbank-id": "DB12775",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Abituzumab"
                    },
                    {
                        "drugbank-id": "DB12797",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ecromeximab"
                    },
                    {
                        "drugbank-id": "DB12807",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Naptumomab Estafenatox"
                    },
                    {
                        "drugbank-id": "DB12815",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Crotedumab"
                    },
                    {
                        "drugbank-id": "DB12820",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Concizumab"
                    },
                    {
                        "drugbank-id": "DB12826",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Depatuxizumab"
                    },
                    {
                        "drugbank-id": "DB12844",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Rontalizumab"
                    },
                    {
                        "drugbank-id": "DB12845",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Amatuximab"
                    },
                    {
                        "drugbank-id": "DB12849",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Clazakizumab"
                    },
                    {
                        "drugbank-id": "DB12891",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ozanezumab"
                    },
                    {
                        "drugbank-id": "DB12893",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Sacituzumab govitecan"
                    },
                    {
                        "drugbank-id": "DB12917",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Bimekizumab"
                    },
                    {
                        "drugbank-id": "DB12943",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Milatuzumab"
                    },
                    {
                        "drugbank-id": "DB12976",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Robatumumab"
                    },
                    {
                        "drugbank-id": "DB13017",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Rovalpituzumab Tesirine"
                    },
                    {
                        "drugbank-id": "DB13037",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Namilumab"
                    },
                    {
                        "drugbank-id": "DB13045",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Racotumomab"
                    },
                    {
                        "drugbank-id": "DB13073",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tregalizumab"
                    },
                    {
                        "drugbank-id": "DB13127",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Olokizumab"
                    },
                    {
                        "drugbank-id": "DB13140",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Bezlotoxumab"
                    },
                    {
                        "drugbank-id": "DB13375",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Edrecolomab"
                    },
                    {
                        "drugbank-id": "DB13535",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Nebacumab"
                    },
                    {
                        "drugbank-id": "DB13886",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Human cytomegalovirus immune globulin"
                    },
                    {
                        "drugbank-id": "DB13923",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Emicizumab"
                    },
                    {
                        "drugbank-id": "DB13976",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Sulesomab"
                    },
                    {
                        "drugbank-id": "DB13979",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Besilesomab"
                    },
                    {
                        "drugbank-id": "DB14012",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Burosumab"
                    },
                    {
                        "drugbank-id": "DB14039",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Erenumab"
                    },
                    {
                        "drugbank-id": "DB14040",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Eptinezumab"
                    },
                    {
                        "drugbank-id": "DB14041",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Fremanezumab"
                    },
                    {
                        "drugbank-id": "DB14042",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Galcanezumab"
                    },
                    {
                        "drugbank-id": "DB14211",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Fanolesomab"
                    },
                    {
                        "drugbank-id": "DB14580",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lecanemab"
                    },
                    {
                        "drugbank-id": "DB14597",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lanadelumab"
                    },
                    {
                        "drugbank-id": "DB14707",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Cemiplimab"
                    },
                    {
                        "drugbank-id": "DB14776",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Camrelizumab"
                    },
                    {
                        "drugbank-id": "DB14778",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Setrusumab"
                    },
                    {
                        "drugbank-id": "DB14809",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Anetumab ravtansine"
                    },
                    {
                        "drugbank-id": "DB14811",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Isatuximab"
                    },
                    {
                        "drugbank-id": "DB14824",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Icrucumab"
                    },
                    {
                        "drugbank-id": "DB14843",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Codrituzumab"
                    },
                    {
                        "drugbank-id": "DB14864",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Brolucizumab"
                    },
                    {
                        "drugbank-id": "DB14871",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Xentuzumab"
                    },
                    {
                        "drugbank-id": "DB14877",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lintuzumab"
                    },
                    {
                        "drugbank-id": "DB14891",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Vobarilizumab"
                    },
                    {
                        "drugbank-id": "DB14897",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Parsatuzumab"
                    },
                    {
                        "drugbank-id": "DB14905",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Emactuzumab"
                    },
                    {
                        "drugbank-id": "DB14907",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Bevacizumab zirconium Zr 89"
                    },
                    {
                        "drugbank-id": "DB14908",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Refanezumab"
                    },
                    {
                        "drugbank-id": "DB14947",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Bermekimab"
                    },
                    {
                        "drugbank-id": "DB14952",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Pamrevlumab"
                    },
                    {
                        "drugbank-id": "DB14959",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Opicinumab"
                    },
                    {
                        "drugbank-id": "DB14962",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Trastuzumab deruxtecan"
                    },
                    {
                        "drugbank-id": "DB14967",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Margetuximab"
                    },
                    {
                        "drugbank-id": "DB14988",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Dalantercept"
                    },
                    {
                        "drugbank-id": "DB14997",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Pateclizumab"
                    },
                    {
                        "drugbank-id": "DB15014",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Gremubamab"
                    },
                    {
                        "drugbank-id": "DB15022",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Apomab"
                    },
                    {
                        "drugbank-id": "DB15044",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tafasitamab"
                    },
                    {
                        "drugbank-id": "DB15045",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ipafricept"
                    },
                    {
                        "drugbank-id": "DB15076",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Abrilumab"
                    },
                    {
                        "drugbank-id": "DB15089",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Frovocimab"
                    },
                    {
                        "drugbank-id": "DB15090",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tezepelumab"
                    },
                    {
                        "drugbank-id": "DB15101",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tigatuzumab"
                    },
                    {
                        "drugbank-id": "DB15104",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Telisotuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15113",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Utomilumab"
                    },
                    {
                        "drugbank-id": "DB15118",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Zolbetuximab"
                    },
                    {
                        "drugbank-id": "DB15135",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ponezumab"
                    },
                    {
                        "drugbank-id": "DB15160",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Asunercept"
                    },
                    {
                        "drugbank-id": "DB15172",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Suvratoxumab"
                    },
                    {
                        "drugbank-id": "DB15225",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Mitazalimab"
                    },
                    {
                        "drugbank-id": "DB15252",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Nemolizumab"
                    },
                    {
                        "drugbank-id": "DB15277",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Gedivumab"
                    },
                    {
                        "drugbank-id": "DB15336",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Valanafusp alfa"
                    },
                    {
                        "drugbank-id": "DB15349",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Sofituzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15354",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Evinacumab"
                    },
                    {
                        "drugbank-id": "DB15363",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Istiratumab"
                    },
                    {
                        "drugbank-id": "DB15383",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Pidilizumab"
                    },
                    {
                        "drugbank-id": "DB15397",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with GMA 161"
                    },
                    {
                        "drugbank-id": "DB15409",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ladiratuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15415",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tomaralimab"
                    },
                    {
                        "drugbank-id": "DB15428",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Vesencumab"
                    },
                    {
                        "drugbank-id": "DB15432",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Pinatuzumab vedotin"
                    },
                    {
                        "drugbank-id": "DB15441",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lulizumab pegol"
                    },
                    {
                        "drugbank-id": "DB15443",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Lorukafusp alfa"
                    },
                    {
                        "drugbank-id": "DB15453",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Naratuximab emtansine"
                    },
                    {
                        "drugbank-id": "DB14004",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Tildrakizumab"
                    },
                    {
                        "drugbank-id": "DB05679",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Ustekinumab"
                    },
                    {
                        "drugbank-id": "DB15559",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Zenocutuzumab"
                    },
                    {
                        "drugbank-id": "DB15898",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Atoltivimab"
                    },
                    {
                        "drugbank-id": "DB15899",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Maftivimab"
                    },
                    {
                        "drugbank-id": "DB15900",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Odesivimab"
                    },
                    {
                        "drugbank-id": "DB15719",
                        "description": "The risk or severity of adverse effects can be increased when Trastuzumab is combined with Belantamab mafodotin"
                    },
                    {
                        "drugbank-id": "DB00091",
                        "description": "Trastuzumab may increase the immunosuppressive activities of Cyclosporine"
                    },
                    {
                        "drugbank-id": "DB15595",
                        "description": "The therapeutic efficacy of Ebola Zaire vaccine live attenuated can be decreased when used in combination with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB14513",
                        "description": "The serum concentration of Magnesium can be decreased when it is combined with Trastuzumab"
                    },
                    {
                        "drugbank-id": "DB01601",
                        "description": "The serum concentration of Trastuzumab can be increased when it is combined with Lopinavir"
                    },
                    {
                        "drugbank-id": "DB00445",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Epirubicin"
                    },
                    {
                        "drugbank-id": "DB00694",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Daunorubicin"
                    },
                    {
                        "drugbank-id": "DB00997",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Doxorubicin"
                    },
                    {
                        "drugbank-id": "DB01177",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Idarubicin"
                    },
                    {
                        "drugbank-id": "DB11616",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Pirarubicin"
                    },
                    {
                        "drugbank-id": "DB06013",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Aldoxorubicin"
                    },
                    {
                        "drugbank-id": "DB14784",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Gancotamab"
                    },
                    {
                        "drugbank-id": "DB00385",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Valrubicin"
                    },
                    {
                        "drugbank-id": "DB04978",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with SP1049C"
                    },
                    {
                        "drugbank-id": "DB06071",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with DTS 201"
                    },
                    {
                        "drugbank-id": "DB06420",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Annamycin"
                    },
                    {
                        "drugbank-id": "DB06810",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Plicamycin"
                    },
                    {
                        "drugbank-id": "DB11617",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Aclarubicin"
                    },
                    {
                        "drugbank-id": "DB11618",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Zorubicin"
                    },
                    {
                        "drugbank-id": "DB12410",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Sabarubicin"
                    },
                    {
                        "drugbank-id": "DB12755",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with Zoptarelin doxorubicin"
                    },
                    {
                        "drugbank-id": "DB13103",
                        "description": "The risk or severity of cardiotoxicity can be increased when Trastuzumab is combined with GPX 150"
                    },
                    {
                        "drugbank-id": "DB12530",
                        "description": "The risk or severity of infection can be increased when Trastuzumab is combined with Inebilizumab"
                    },
                    {
                        "drugbank-id": "DB15258",
                        "description": "The therapeutic efficacy of Trastuzumab can be decreased when used in combination with Imlifidase"
                    }
                ]
            }
        },
        "revision_date": "2023-05-14"
    }
}